Cargando…

Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young

BACKGROUND: Studies of the role of iron in the risk of type 1 diabetes (T1D) have been inconsistent. Given that iron generates reactive oxygen radicals, which can lead to oxidative damage and apoptosis in the beta cells of the pancreas, we examined whether iron intake was associated with the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhassan, Sulafa, Dong, Fran, Buckner, Teresa, Johnson, Randi K., Seifert, Jennifer A., Carry, Patrick M., Vanderlinden, Lauren, Waugh, Kathleen, Rewers, Marian, Norris, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086157/
https://www.ncbi.nlm.nih.gov/pubmed/37056761
http://dx.doi.org/10.3389/fimmu.2023.1124370
_version_ 1785022087037976576
author Elhassan, Sulafa
Dong, Fran
Buckner, Teresa
Johnson, Randi K.
Seifert, Jennifer A.
Carry, Patrick M.
Vanderlinden, Lauren
Waugh, Kathleen
Rewers, Marian
Norris, Jill M.
author_facet Elhassan, Sulafa
Dong, Fran
Buckner, Teresa
Johnson, Randi K.
Seifert, Jennifer A.
Carry, Patrick M.
Vanderlinden, Lauren
Waugh, Kathleen
Rewers, Marian
Norris, Jill M.
author_sort Elhassan, Sulafa
collection PubMed
description BACKGROUND: Studies of the role of iron in the risk of type 1 diabetes (T1D) have been inconsistent. Given that iron generates reactive oxygen radicals, which can lead to oxidative damage and apoptosis in the beta cells of the pancreas, we examined whether iron intake was associated with the risk of progressing to T1D in individuals with islet autoimmunity (IA), the pre-clinical phase of T1D. METHODS: DAISY is a prospective cohort following 2,547 children at increased risk for IA and progression to T1D. IA is defined as at least two consecutive serum samples positive for at least one autoantibody (insulin, GAD, IA-2, or ZnT8). We measured dietary intake at the time of IA seroconversion in 175 children with IA, and of these, 64 progressed to T1D. We used Cox regression to examine the association between energy-adjusted iron intake and progression to T1D, adjusting for HLA-DR3/4 genotype, race/ethnicity, age at seroconversion, presence of multiple autoantibodies at seroconversion, and multiple vitamin use. In addition, we tested whether this association was modified by vitamin C or calcium intake. RESULTS: In children with IA, high iron intake (as defined as above the 75th percentile, > 20.3 mg/day) was associated with decreased risk of progression to T1D compared to moderate iron intake (as defined by the middle 25-75th percentiles, 12.7-20.3 mg/day) (adjusted hazard ratio (HR): 0.35; 95% confidence interval (CI): 0.15, 0.79). The association between iron intake and T1D was not modified by vitamin C nor calcium intake. In a sensitivity analysis, the removal of six children who had been diagnosed with celiac disease prior to IA seroconversion did not affect this association. CONCLUSION: Higher iron intake at the time of IA seroconversion is associated with a lower risk of progression to T1D, independent of multivitamin supplement use. Further research that includes plasma biomarkers of iron status is needed to investigate the relationship between iron and the risk of T1D.
format Online
Article
Text
id pubmed-10086157
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100861572023-04-12 Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young Elhassan, Sulafa Dong, Fran Buckner, Teresa Johnson, Randi K. Seifert, Jennifer A. Carry, Patrick M. Vanderlinden, Lauren Waugh, Kathleen Rewers, Marian Norris, Jill M. Front Immunol Immunology BACKGROUND: Studies of the role of iron in the risk of type 1 diabetes (T1D) have been inconsistent. Given that iron generates reactive oxygen radicals, which can lead to oxidative damage and apoptosis in the beta cells of the pancreas, we examined whether iron intake was associated with the risk of progressing to T1D in individuals with islet autoimmunity (IA), the pre-clinical phase of T1D. METHODS: DAISY is a prospective cohort following 2,547 children at increased risk for IA and progression to T1D. IA is defined as at least two consecutive serum samples positive for at least one autoantibody (insulin, GAD, IA-2, or ZnT8). We measured dietary intake at the time of IA seroconversion in 175 children with IA, and of these, 64 progressed to T1D. We used Cox regression to examine the association between energy-adjusted iron intake and progression to T1D, adjusting for HLA-DR3/4 genotype, race/ethnicity, age at seroconversion, presence of multiple autoantibodies at seroconversion, and multiple vitamin use. In addition, we tested whether this association was modified by vitamin C or calcium intake. RESULTS: In children with IA, high iron intake (as defined as above the 75th percentile, > 20.3 mg/day) was associated with decreased risk of progression to T1D compared to moderate iron intake (as defined by the middle 25-75th percentiles, 12.7-20.3 mg/day) (adjusted hazard ratio (HR): 0.35; 95% confidence interval (CI): 0.15, 0.79). The association between iron intake and T1D was not modified by vitamin C nor calcium intake. In a sensitivity analysis, the removal of six children who had been diagnosed with celiac disease prior to IA seroconversion did not affect this association. CONCLUSION: Higher iron intake at the time of IA seroconversion is associated with a lower risk of progression to T1D, independent of multivitamin supplement use. Further research that includes plasma biomarkers of iron status is needed to investigate the relationship between iron and the risk of T1D. Frontiers Media S.A. 2023-03-28 /pmc/articles/PMC10086157/ /pubmed/37056761 http://dx.doi.org/10.3389/fimmu.2023.1124370 Text en Copyright © 2023 Elhassan, Dong, Buckner, Johnson, Seifert, Carry, Vanderlinden, Waugh, Rewers and Norris https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Elhassan, Sulafa
Dong, Fran
Buckner, Teresa
Johnson, Randi K.
Seifert, Jennifer A.
Carry, Patrick M.
Vanderlinden, Lauren
Waugh, Kathleen
Rewers, Marian
Norris, Jill M.
Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young
title Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young
title_full Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young
title_fullStr Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young
title_full_unstemmed Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young
title_short Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young
title_sort investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: the diabetes autoimmunity study in the young
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086157/
https://www.ncbi.nlm.nih.gov/pubmed/37056761
http://dx.doi.org/10.3389/fimmu.2023.1124370
work_keys_str_mv AT elhassansulafa investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT dongfran investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT bucknerteresa investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT johnsonrandik investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT seifertjennifera investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT carrypatrickm investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT vanderlindenlauren investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT waughkathleen investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT rewersmarian investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung
AT norrisjillm investigatingironintakeinriskofprogressionfromisletautoimmunitytotype1diabetesthediabetesautoimmunitystudyintheyoung